

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 9.16827251 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 9.16827251 |
| 3 | endocrine pancreas development (GO:0031018) | 6.91067468 |
| 4 | positive regulation of glycogen biosynthetic process (GO:0045725) | 6.83228131 |
| 5 | negative regulation of gluconeogenesis (GO:0045721) | 6.31891626 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.09863099 |
| 7 | peptide hormone processing (GO:0016486) | 5.94900573 |
| 8 | positive regulation of glycogen metabolic process (GO:0070875) | 5.91442264 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.70994295 |
| 10 | type B pancreatic cell development (GO:0003323) | 5.68036755 |
| 11 | protein maturation by protein folding (GO:0022417) | 5.59461777 |
| 12 | COPII vesicle coating (GO:0048208) | 5.56017478 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 5.41566041 |
| 14 | fatty acid homeostasis (GO:0055089) | 5.36585911 |
| 15 | negative regulation of protein oligomerization (GO:0032460) | 5.35380005 |
| 16 | glandular epithelial cell development (GO:0002068) | 5.28150283 |
| 17 | protein retention in ER lumen (GO:0006621) | 5.26413457 |
| 18 | negative regulation of hormone biosynthetic process (GO:0032353) | 5.16623073 |
| 19 | positive regulation of respiratory burst (GO:0060267) | 5.09316494 |
| 20 | insulin secretion (GO:0030073) | 5.07605375 |
| 21 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.05486583 |
| 22 | negative regulation of acute inflammatory response (GO:0002674) | 4.98913757 |
| 23 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.92993631 |
| 24 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.86191610 |
| 25 | regulation of glucokinase activity (GO:0033131) | 4.68259694 |
| 26 | regulation of hexokinase activity (GO:1903299) | 4.68259694 |
| 27 | positive regulation of nuclease activity (GO:0032075) | 4.66019321 |
| 28 | negative regulation of hormone metabolic process (GO:0032351) | 4.61065883 |
| 29 | exocrine pancreas development (GO:0031017) | 4.50761445 |
| 30 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.46176138 |
| 31 | * positive regulation of insulin secretion (GO:0032024) | 4.38547763 |
| 32 | negative regulation of glycogen metabolic process (GO:0070874) | 4.37991848 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.36918122 |
| 34 | ER overload response (GO:0006983) | 4.33338675 |
| 35 | toxin metabolic process (GO:0009404) | 4.27724603 |
| 36 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.27662927 |
| 37 | regulation of nuclease activity (GO:0032069) | 4.26928367 |
| 38 | sequestering of metal ion (GO:0051238) | 4.24645872 |
| 39 | response to lead ion (GO:0010288) | 4.20252776 |
| 40 | positive regulation of macroautophagy (GO:0016239) | 4.20077864 |
| 41 | vesicle coating (GO:0006901) | 4.17596754 |
| 42 | nucleoside diphosphate catabolic process (GO:0009134) | 4.12098379 |
| 43 | * regulation of insulin secretion (GO:0050796) | 4.05489585 |
| 44 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.03272500 |
| 45 | signal peptide processing (GO:0006465) | 3.98376309 |
| 46 | cellular response to unfolded protein (GO:0034620) | 3.96346063 |
| 47 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.92483815 |
| 48 | drug transmembrane transport (GO:0006855) | 3.90846663 |
| 49 | peptide hormone secretion (GO:0030072) | 3.88600624 |
| 50 | positive regulation of glucose metabolic process (GO:0010907) | 3.85843485 |
| 51 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.83891112 |
| 52 | lactate metabolic process (GO:0006089) | 3.81264066 |
| 53 | peptide secretion (GO:0002790) | 3.81064662 |
| 54 | cellular response to topologically incorrect protein (GO:0035967) | 3.80771674 |
| 55 | ER-nucleus signaling pathway (GO:0006984) | 3.79509676 |
| 56 | nitric oxide mediated signal transduction (GO:0007263) | 3.79238977 |
| 57 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.75424681 |
| 58 | regulation of glycogen biosynthetic process (GO:0005979) | 3.69192795 |
| 59 | regulation of glucan biosynthetic process (GO:0010962) | 3.69192795 |
| 60 | * regulation of peptide hormone secretion (GO:0090276) | 3.66617980 |
| 61 | positive regulation of response to nutrient levels (GO:0032109) | 3.65054079 |
| 62 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.65054079 |
| 63 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.62425892 |
| 64 | regulation of glycolytic process (GO:0006110) | 3.60511612 |
| 65 | * regulation of peptide secretion (GO:0002791) | 3.59634683 |
| 66 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.55720878 |
| 67 | epithelial cell fate commitment (GO:0072148) | 3.55572512 |
| 68 | macroautophagy (GO:0016236) | 3.53273160 |
| 69 | * positive regulation of peptide hormone secretion (GO:0090277) | 3.50855026 |
| 70 | positive regulation of Rap GTPase activity (GO:0032854) | 3.48644265 |
| 71 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.48448682 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 3.47307875 |
| 73 | regulation of protein glycosylation (GO:0060049) | 3.43780843 |
| 74 | negative regulation of neurological system process (GO:0031645) | 3.43485318 |
| 75 | positive regulation of protein autophosphorylation (GO:0031954) | 3.42938331 |
| 76 | * positive regulation of peptide secretion (GO:0002793) | 3.36848723 |
| 77 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.33501126 |
| 78 | response to endoplasmic reticulum stress (GO:0034976) | 3.31857935 |
| 79 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.29541240 |
| 80 | inner ear receptor cell development (GO:0060119) | 3.29314848 |
| 81 | negative regulation of norepinephrine secretion (GO:0010700) | 3.29278567 |
| 82 | trivalent inorganic anion homeostasis (GO:0072506) | 3.29168711 |
| 83 | phosphate ion homeostasis (GO:0055062) | 3.29168711 |
| 84 | tricarboxylic acid metabolic process (GO:0072350) | 3.27977130 |
| 85 | inositol phosphate catabolic process (GO:0071545) | 3.27619021 |
| 86 | negative regulation of insulin secretion (GO:0046676) | 3.26961648 |
| 87 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.26928192 |
| 88 | regulation of energy homeostasis (GO:2000505) | 3.26722862 |
| 89 | positive regulation of cellular carbohydrate metabolic process (GO:0010676) | 3.25028439 |
| 90 | negative regulation of Ras GTPase activity (GO:0034261) | 3.23180389 |
| 91 | astrocyte differentiation (GO:0048708) | 3.21844704 |
| 92 | cellular response to glucagon stimulus (GO:0071377) | 3.21242796 |
| 93 | 4-hydroxyproline metabolic process (GO:0019471) | 3.18516312 |
| 94 | regulation of glycogen metabolic process (GO:0070873) | 3.18138394 |
| 95 | Golgi organization (GO:0007030) | 3.17183786 |
| 96 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.17122419 |
| 97 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.16254973 |
| 98 | negative regulation of JUN kinase activity (GO:0043508) | 3.15917583 |
| 99 | * regulation of hormone secretion (GO:0046883) | 3.15284926 |
| 100 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.13937422 |
| 101 | peptidyl-asparagine modification (GO:0018196) | 3.13024046 |
| 102 | peptide transport (GO:0015833) | 3.11000094 |
| 103 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.08833313 |
| 104 | inositol phosphate dephosphorylation (GO:0046855) | 3.08833313 |
| 105 | positive regulation of carbohydrate metabolic process (GO:0045913) | 3.08156617 |
| 106 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.06456410 |
| 107 | intestinal epithelial cell development (GO:0060576) | 3.05699461 |
| 108 | regulation of polysaccharide biosynthetic process (GO:0032885) | 3.02911421 |
| 109 | response to unfolded protein (GO:0006986) | 3.02104377 |
| 110 | protein localization to Golgi apparatus (GO:0034067) | 3.01627772 |
| 111 | negative regulation of catecholamine secretion (GO:0033604) | 3.01284346 |
| 112 | hormone secretion (GO:0046879) | 3.00565684 |
| 113 | protein targeting to Golgi (GO:0000042) | 3.00446304 |
| 114 | positive regulation of glycolytic process (GO:0045821) | 2.99419522 |
| 115 | regulation of glucocorticoid secretion (GO:2000849) | 2.96479368 |
| 116 | * regulation of peptide transport (GO:0090087) | 2.96016763 |
| 117 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.95239670 |
| 118 | positive regulation of glucose import (GO:0046326) | 2.93448639 |
| 119 | response to parathyroid hormone (GO:0071107) | 2.92573135 |
| 120 | protein N-linked glycosylation (GO:0006487) | 2.91555875 |
| 121 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.91020341 |
| 122 | hormone transport (GO:0009914) | 2.90772771 |
| 123 | response to topologically incorrect protein (GO:0035966) | 2.90371084 |
| 124 | membrane repolarization during action potential (GO:0086011) | 2.88632514 |
| 125 | cellular zinc ion homeostasis (GO:0006882) | 2.85932650 |
| 126 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.85015408 |
| 127 | regulation of carbohydrate catabolic process (GO:0043470) | 2.85015408 |
| 128 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.83701469 |
| 129 | regulation of Rap GTPase activity (GO:0032317) | 2.82866705 |
| 130 | potassium ion homeostasis (GO:0055075) | 2.82828831 |
| 131 | negative regulation of peptide hormone secretion (GO:0090278) | 2.82527166 |
| 132 | cerebellar Purkinje cell layer development (GO:0021680) | 2.80737632 |
| 133 | positive regulation of growth hormone secretion (GO:0060124) | 2.80429586 |
| 134 | positive regulation of autophagy (GO:0010508) | 2.80149851 |
| 135 | phospholipid dephosphorylation (GO:0046839) | 2.79926525 |
| 136 | inositol phosphate-mediated signaling (GO:0048016) | 2.79873588 |
| 137 | negative regulation of digestive system process (GO:0060457) | 2.79774175 |
| 138 | * positive regulation of hormone secretion (GO:0046887) | 2.78939732 |
| 139 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.77780166 |
| 140 | positive regulation of vasodilation (GO:0045909) | 2.76624223 |
| 141 | negative regulation of peptide secretion (GO:0002792) | 2.74530315 |
| 142 | protein autoprocessing (GO:0016540) | 2.73022673 |
| 143 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.72848670 |
| 144 | toxin transport (GO:1901998) | 2.72814554 |
| 145 | regulation of gluconeogenesis (GO:0006111) | 2.72571732 |
| 146 | * carbohydrate homeostasis (GO:0033500) | 2.72376795 |
| 147 | * glucose homeostasis (GO:0042593) | 2.72376795 |
| 148 | intestinal absorption (GO:0050892) | 2.72319879 |
| 149 | kidney morphogenesis (GO:0060993) | 2.72226306 |
| 150 | pancreas development (GO:0031016) | 2.71173866 |
| 151 | catecholamine biosynthetic process (GO:0042423) | 2.71056361 |
| 152 | catechol-containing compound biosynthetic process (GO:0009713) | 2.71056361 |
| 153 | * response to hexose (GO:0009746) | 2.70412077 |
| 154 | magnesium ion transport (GO:0015693) | 2.69217012 |
| 155 | regulation of polysaccharide metabolic process (GO:0032881) | 2.69028110 |
| 156 | * response to glucose (GO:0009749) | 2.68090349 |
| 157 | relaxation of cardiac muscle (GO:0055119) | 2.67058892 |
| 158 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.66119010 |
| 159 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.66119010 |
| 160 | cellular ketone body metabolic process (GO:0046950) | 2.65974469 |
| 161 | growth hormone secretion (GO:0030252) | 2.65836086 |
| 162 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.65596271 |
| 163 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.64866060 |
| 164 | zinc ion homeostasis (GO:0055069) | 2.64836437 |
| 165 | amide transport (GO:0042886) | 2.64639256 |
| 166 | peptide catabolic process (GO:0043171) | 2.63342370 |
| 167 | myelin maintenance (GO:0043217) | 2.62899250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.14597708 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.12973775 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.48740496 |
| 4 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.31372848 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06500479 |
| 6 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.98111646 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96766420 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84153556 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82743491 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79407898 |
| 11 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.78505856 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74615448 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72397742 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.71594480 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67314162 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60952378 |
| 17 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60220886 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59761544 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59212672 |
| 20 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59132285 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54855493 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54028107 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53993789 |
| 24 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.53255619 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.47465769 |
| 26 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47058052 |
| 27 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43629220 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42485899 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41462632 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40377358 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39138842 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38637401 |
| 33 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37057873 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36452009 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35758910 |
| 36 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35679261 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35662271 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33726671 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31213896 |
| 40 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29677409 |
| 41 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29146033 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28928330 |
| 43 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28449850 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28302958 |
| 45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28174713 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27827256 |
| 47 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27788795 |
| 48 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27308933 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26784382 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26466791 |
| 51 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24062812 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23536529 |
| 53 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22365018 |
| 54 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.21076247 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19351729 |
| 56 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19085012 |
| 57 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18685560 |
| 58 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18533615 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18466968 |
| 60 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.18204467 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17756836 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17690464 |
| 63 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16395860 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15837456 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15741845 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15337492 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14811049 |
| 68 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14563705 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14317600 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14235998 |
| 71 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13817610 |
| 72 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13813489 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12916622 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11267741 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10626969 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10100668 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09912851 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09118935 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08396665 |
| 80 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08302843 |
| 81 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07539891 |
| 82 | CBP_21632823_ChIP-Seq_H3396_Human | 1.07077659 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06905424 |
| 84 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06237401 |
| 85 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05877334 |
| 86 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05731015 |
| 87 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05442795 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05409786 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04563002 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04388156 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04072340 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03933654 |
| 93 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03902611 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03590637 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03433794 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03281311 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03194486 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02721297 |
| 99 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02613554 |
| 100 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02428093 |
| 101 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02140268 |
| 102 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01924448 |
| 103 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.01686738 |
| 104 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00747696 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00501554 |
| 106 | AR_19668381_ChIP-Seq_PC3_Human | 1.00250486 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99611074 |
| 108 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99012283 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99012283 |
| 110 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97560934 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97002634 |
| 112 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.96935277 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96604960 |
| 114 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96219690 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95332829 |
| 116 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95236284 |
| 117 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95114837 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95014295 |
| 119 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92787370 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92786312 |
| 121 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92075471 |
| 122 | * GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.92070670 |
| 123 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91170201 |
| 124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90096147 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89178081 |
| 126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89062017 |
| 127 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88528360 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88387574 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88259398 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87334881 |
| 131 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.87255794 |
| 132 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87220154 |
| 133 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87107274 |
| 134 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86701075 |
| 135 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86393113 |
| 136 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85701375 |
| 137 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85701375 |
| 138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85272740 |
| 139 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83809683 |
| 140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83794060 |
| 141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83283956 |
| 142 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83247047 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83025529 |
| 144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81923471 |
| 145 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81846752 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81776137 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.81439263 |
| 148 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.81186588 |
| 149 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81030999 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80542507 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80278065 |
| 152 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79787380 |
| 153 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.79472498 |
| 154 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79402098 |
| 155 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.78992485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 5.51089337 |
| 2 | MP0003283_abnormal_digestive_organ | 5.25902385 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 4.48767219 |
| 4 | MP0002693_abnormal_pancreas_physiology | 4.06852352 |
| 5 | MP0003123_paternal_imprinting | 4.00044584 |
| 6 | MP0000013_abnormal_adipose_tissue | 3.92624477 |
| 7 | MP0002909_abnormal_adrenal_gland | 3.82113324 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.77464472 |
| 9 | MP0001944_abnormal_pancreas_morphology | 3.67564363 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.60390288 |
| 11 | MP0005379_endocrine/exocrine_gland_phen | 3.01366624 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.90559648 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.89172031 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.86279616 |
| 15 | MP0005220_abnormal_exocrine_pancreas | 2.52628778 |
| 16 | MP0002078_abnormal_glucose_homeostasis | 2.36933574 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.27115211 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.24880879 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.22881250 |
| 20 | * MP0001765_abnormal_ion_homeostasis | 2.15788871 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 2.13176454 |
| 22 | MP0000003_abnormal_adipose_tissue | 2.11463502 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 2.10412956 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.06789330 |
| 25 | * MP0000678_abnormal_parathyroid_gland | 1.98479826 |
| 26 | * MP0009643_abnormal_urine_homeostasis | 1.87572420 |
| 27 | MP0002938_white_spotting | 1.86961140 |
| 28 | MP0002928_abnormal_bile_duct | 1.86471894 |
| 29 | MP0003121_genomic_imprinting | 1.84893662 |
| 30 | MP0004510_myositis | 1.84271054 |
| 31 | MP0002234_abnormal_pharynx_morphology | 1.83131182 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.79447513 |
| 33 | MP0003252_abnormal_bile_duct | 1.76603898 |
| 34 | MP0004270_analgesia | 1.73591261 |
| 35 | * MP0002896_abnormal_bone_mineralization | 1.72073793 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.71711154 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.69293458 |
| 38 | MP0001756_abnormal_urination | 1.67764570 |
| 39 | MP0000462_abnormal_digestive_system | 1.65376808 |
| 40 | * MP0003195_calcinosis | 1.63776969 |
| 41 | MP0003122_maternal_imprinting | 1.58100627 |
| 42 | MP0002822_catalepsy | 1.55628889 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.53656487 |
| 44 | MP0005365_abnormal_bile_salt | 1.40007698 |
| 45 | MP0003045_fibrosis | 1.38894907 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.38414408 |
| 47 | * MP0003953_abnormal_hormone_level | 1.33783661 |
| 48 | MP0009046_muscle_twitch | 1.32405385 |
| 49 | MP0000613_abnormal_salivary_gland | 1.30008242 |
| 50 | MP0003959_abnormal_lean_body | 1.28485558 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.27304332 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.27217127 |
| 53 | MP0008004_abnormal_stomach_pH | 1.26416752 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.24931466 |
| 55 | * MP0005636_abnormal_mineral_homeostasis | 1.23397522 |
| 56 | MP0005310_abnormal_salivary_gland | 1.18870982 |
| 57 | MP0005535_abnormal_body_temperature | 1.17432816 |
| 58 | MP0002090_abnormal_vision | 1.15778636 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.15089081 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.09800717 |
| 61 | MP0000631_abnormal_neuroendocrine_gland | 1.09601645 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.09407358 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.08665896 |
| 64 | MP0003868_abnormal_feces_composition | 1.07471782 |
| 65 | MP0005332_abnormal_amino_acid | 1.07411180 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.06651764 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.06123036 |
| 68 | MP0003633_abnormal_nervous_system | 1.05979202 |
| 69 | MP0001270_distended_abdomen | 1.01718038 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.01694179 |
| 71 | MP0000538_abnormal_urinary_bladder | 1.01621454 |
| 72 | MP0005257_abnormal_intraocular_pressure | 0.99962479 |
| 73 | MP0001984_abnormal_olfaction | 0.96104461 |
| 74 | MP0010678_abnormal_skin_adnexa | 0.94486297 |
| 75 | MP0002971_abnormal_brown_adipose | 0.94192037 |
| 76 | MP0001666_abnormal_nutrient_absorption | 0.90985145 |
| 77 | MP0003119_abnormal_digestive_system | 0.89849326 |
| 78 | MP0003011_delayed_dark_adaptation | 0.85613405 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.85607181 |
| 80 | MP0004885_abnormal_endolymph | 0.83324824 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.82461646 |
| 82 | MP0002269_muscular_atrophy | 0.82461083 |
| 83 | MP0003879_abnormal_hair_cell | 0.82120700 |
| 84 | MP0009672_abnormal_birth_weight | 0.81714758 |
| 85 | MP0005670_abnormal_white_adipose | 0.78410659 |
| 86 | MP0001727_abnormal_embryo_implantation | 0.77082614 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.76261567 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.76200576 |
| 89 | MP0004924_abnormal_behavior | 0.74408871 |
| 90 | MP0005386_behavior/neurological_phenoty | 0.74408871 |
| 91 | MP0001661_extended_life_span | 0.72567685 |
| 92 | MP0001346_abnormal_lacrimal_gland | 0.72119529 |
| 93 | MP0000427_abnormal_hair_cycle | 0.71946522 |
| 94 | MP0000747_muscle_weakness | 0.71889095 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.70556635 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.70521582 |
| 97 | MP0002272_abnormal_nervous_system | 0.69598649 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.69468386 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.69129251 |
| 100 | MP0005253_abnormal_eye_physiology | 0.68355257 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.66787137 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.66424466 |
| 103 | MP0002572_abnormal_emotion/affect_behav | 0.66374089 |
| 104 | * MP0002168_other_aberrant_phenotype | 0.66320835 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.65974866 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.65492414 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.64885737 |
| 108 | MP0009703_decreased_birth_body | 0.64560040 |
| 109 | MP0006054_spinal_hemorrhage | 0.64485504 |
| 110 | MP0003787_abnormal_imprinting | 0.64415383 |
| 111 | MP0005448_abnormal_energy_balance | 0.63204093 |
| 112 | MP0002064_seizures | 0.63120461 |
| 113 | MP0003866_abnormal_defecation | 0.61844407 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.61219359 |
| 115 | MP0009745_abnormal_behavioral_response | 0.60917708 |
| 116 | MP0004859_abnormal_synaptic_plasticity | 0.60528330 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.60353289 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.59731999 |
| 119 | MP0002229_neurodegeneration | 0.59250500 |
| 120 | MP0005452_abnormal_adipose_tissue | 0.59218617 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.58547726 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.58413728 |
| 123 | * MP0002069_abnormal_eating/drinking_beha | 0.57967730 |
| 124 | MP0005334_abnormal_fat_pad | 0.56586447 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.56262051 |
| 126 | MP0004134_abnormal_chest_morphology | 0.55917455 |
| 127 | MP0000955_abnormal_spinal_cord | 0.55917286 |
| 128 | MP0009840_abnormal_foam_cell | 0.55019098 |
| 129 | MP0004858_abnormal_nervous_system | 0.55012916 |
| 130 | MP0002557_abnormal_social/conspecific_i | 0.54912191 |
| 131 | MP0000516_abnormal_urinary_system | 0.54424808 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.54424808 |
| 133 | * MP0009642_abnormal_blood_homeostasis | 0.53219561 |
| 134 | MP0003634_abnormal_glial_cell | 0.52684084 |
| 135 | MP0002160_abnormal_reproductive_system | 0.51114634 |
| 136 | * MP0002136_abnormal_kidney_physiology | 0.50902832 |
| 137 | MP0005187_abnormal_penis_morphology | 0.50535632 |
| 138 | * MP0001731_abnormal_postnatal_growth | 0.49084323 |
| 139 | MP0002163_abnormal_gland_morphology | 0.49016725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.09473285 |
| 2 | * Hyperphosphatemia (HP:0002905) | 7.35255493 |
| 3 | * Tetany (HP:0001281) | 7.21072323 |
| 4 | Hypoglycemic seizures (HP:0002173) | 7.17392641 |
| 5 | Symptomatic seizures (HP:0011145) | 6.68986309 |
| 6 | Hypoglycemic coma (HP:0001325) | 6.36954173 |
| 7 | Ketoacidosis (HP:0001993) | 5.35664356 |
| 8 | Hyperglycemia (HP:0003074) | 5.29983177 |
| 9 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.27901044 |
| 10 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.06553449 |
| 11 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.94756001 |
| 12 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.94756001 |
| 13 | * Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.75109325 |
| 14 | Large for gestational age (HP:0001520) | 4.59468176 |
| 15 | Late onset (HP:0003584) | 4.41140303 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 4.22156904 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 4.16217288 |
| 18 | * Hypokalemia (HP:0002900) | 4.02173188 |
| 19 | * Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.89838414 |
| 20 | Abnormality of chloride homeostasis (HP:0011422) | 3.83992404 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.80247638 |
| 22 | Decreased circulating renin level (HP:0003351) | 3.76131446 |
| 23 | Gout (HP:0001997) | 3.69751861 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.63358031 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63358031 |
| 26 | Osteomalacia (HP:0002749) | 3.62587494 |
| 27 | Abnormal pancreas size (HP:0012094) | 3.53101286 |
| 28 | Metabolic alkalosis (HP:0200114) | 3.52316733 |
| 29 | * Abnormality of potassium homeostasis (HP:0011042) | 3.43231671 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33020412 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33020412 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33020412 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.19440118 |
| 34 | Alacrima (HP:0000522) | 3.19237135 |
| 35 | Hyperkalemia (HP:0002153) | 3.15723895 |
| 36 | * Abnormality of renin-angiotensin system (HP:0000847) | 3.15405055 |
| 37 | Agitation (HP:0000713) | 3.14821793 |
| 38 | Ketosis (HP:0001946) | 3.10775220 |
| 39 | Type I diabetes mellitus (HP:0100651) | 3.10101368 |
| 40 | Enlarged penis (HP:0000040) | 3.09779293 |
| 41 | Hyperaldosteronism (HP:0000859) | 3.01996131 |
| 42 | Unilateral renal agenesis (HP:0000122) | 2.98877961 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96163662 |
| 44 | Insulin resistance (HP:0000855) | 2.93917462 |
| 45 | * Increased circulating renin level (HP:0000848) | 2.91574435 |
| 46 | Decreased lacrimation (HP:0000633) | 2.83623549 |
| 47 | Hypoparathyroidism (HP:0000829) | 2.83324539 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.79443376 |
| 49 | Hyperthyroidism (HP:0000836) | 2.78849570 |
| 50 | Prominent metopic ridge (HP:0005487) | 2.74551796 |
| 51 | Retinal atrophy (HP:0001105) | 2.65500359 |
| 52 | Alkalosis (HP:0001948) | 2.55804571 |
| 53 | Adrenal overactivity (HP:0002717) | 2.55214672 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.55067752 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.53137375 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48822170 |
| 57 | Abnormality of the metopic suture (HP:0005556) | 2.42425563 |
| 58 | * Hypocalcemia (HP:0002901) | 2.41960672 |
| 59 | Downturned corners of mouth (HP:0002714) | 2.39370547 |
| 60 | Hypsarrhythmia (HP:0002521) | 2.35878419 |
| 61 | Testicular neoplasm (HP:0010788) | 2.35597997 |
| 62 | Renal salt wasting (HP:0000127) | 2.35390164 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33991916 |
| 64 | * Polyuria (HP:0000103) | 2.32687581 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.26104030 |
| 66 | Glycosuria (HP:0003076) | 2.26104030 |
| 67 | Muscular hypotonia of the trunk (HP:0008936) | 2.23698116 |
| 68 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21530439 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.21434107 |
| 70 | Neoplasm of the adrenal cortex (HP:0100641) | 2.20441138 |
| 71 | * Hypomagnesemia (HP:0002917) | 2.20433355 |
| 72 | Abdominal distention (HP:0003270) | 2.16436069 |
| 73 | Protuberant abdomen (HP:0001538) | 2.16102511 |
| 74 | Pheochromocytoma (HP:0002666) | 2.14377992 |
| 75 | * Abnormal urine output (HP:0012590) | 2.13236118 |
| 76 | Hepatoblastoma (HP:0002884) | 2.12279996 |
| 77 | Tongue fasciculations (HP:0001308) | 2.12262887 |
| 78 | * Hypophosphatemia (HP:0002148) | 2.10685933 |
| 79 | Papilledema (HP:0001085) | 2.09707909 |
| 80 | Hypokinesia (HP:0002375) | 2.08948589 |
| 81 | Increased purine levels (HP:0004368) | 2.08793348 |
| 82 | Hyperuricemia (HP:0002149) | 2.08793348 |
| 83 | Hypercortisolism (HP:0001578) | 2.08433213 |
| 84 | Fair hair (HP:0002286) | 2.03761746 |
| 85 | * Hyperparathyroidism (HP:0000843) | 2.01558613 |
| 86 | Exocrine pancreatic insufficiency (HP:0001738) | 2.01320499 |
| 87 | * Abnormality of renal excretion (HP:0011036) | 2.01058679 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.00818528 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 1.99640254 |
| 90 | Congenital glaucoma (HP:0001087) | 1.99373135 |
| 91 | Limb hypertonia (HP:0002509) | 1.98967043 |
| 92 | Metaphyseal dysplasia (HP:0100255) | 1.98410939 |
| 93 | Abnormal sex determination (HP:0012244) | 1.96343687 |
| 94 | Sex reversal (HP:0012245) | 1.96343687 |
| 95 | Enlarged kidneys (HP:0000105) | 1.94567440 |
| 96 | Dysautonomia (HP:0002459) | 1.93320130 |
| 97 | Ventricular fibrillation (HP:0001663) | 1.93156555 |
| 98 | Vascular calcification (HP:0004934) | 1.92494817 |
| 99 | Disproportionate short-trunk short stature (HP:0003521) | 1.88444526 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88306847 |
| 101 | Intention tremor (HP:0002080) | 1.86508905 |
| 102 | Thickened calvaria (HP:0002684) | 1.84718455 |
| 103 | Delayed epiphyseal ossification (HP:0002663) | 1.83594625 |
| 104 | Hypothermia (HP:0002045) | 1.82522608 |
| 105 | Restlessness (HP:0000711) | 1.81698256 |
| 106 | Severe short stature (HP:0003510) | 1.81682023 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 1.80806019 |
| 108 | * Hypotension (HP:0002615) | 1.80641509 |
| 109 | Macroorchidism (HP:0000053) | 1.80455345 |
| 110 | Hamartoma of the eye (HP:0010568) | 1.79914922 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79157067 |
| 112 | Muscle fibrillation (HP:0010546) | 1.76828963 |
| 113 | Germ cell neoplasia (HP:0100728) | 1.75155109 |
| 114 | Hyponatremia (HP:0002902) | 1.75003117 |
| 115 | Neuroendocrine neoplasm (HP:0100634) | 1.74602118 |
| 116 | Thin bony cortex (HP:0002753) | 1.74441963 |
| 117 | Thoracolumbar scoliosis (HP:0002944) | 1.73706402 |
| 118 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73698251 |
| 119 | Villous atrophy (HP:0011473) | 1.73698251 |
| 120 | * Abnormality of magnesium homeostasis (HP:0004921) | 1.73279180 |
| 121 | Increased density of long bones (HP:0006392) | 1.71138708 |
| 122 | Mixed hearing impairment (HP:0000410) | 1.70223613 |
| 123 | Hypoplastic labia majora (HP:0000059) | 1.69630487 |
| 124 | Skin nodule (HP:0200036) | 1.69428760 |
| 125 | * Hyperphosphaturia (HP:0003109) | 1.69377496 |
| 126 | Septate vagina (HP:0001153) | 1.68088543 |
| 127 | * Abnormal drinking behavior (HP:0030082) | 1.67492402 |
| 128 | * Polydipsia (HP:0001959) | 1.67492402 |
| 129 | Menstrual irregularities (HP:0000858) | 1.67244524 |
| 130 | Myoglobinuria (HP:0002913) | 1.65616296 |
| 131 | Progressive neurologic deterioration (HP:0002344) | 1.64664979 |
| 132 | Conjunctival hamartoma (HP:0100780) | 1.63634447 |
| 133 | Lower limb hyperreflexia (HP:0002395) | 1.62549690 |
| 134 | Calf muscle hypertrophy (HP:0008981) | 1.61584670 |
| 135 | Cardiovascular calcification (HP:0011915) | 1.60473063 |
| 136 | Small for gestational age (HP:0001518) | 1.58420454 |
| 137 | Generalized hypopigmentation of hair (HP:0011358) | 1.57424243 |
| 138 | Hepatic necrosis (HP:0002605) | 1.56767981 |
| 139 | Anxiety (HP:0000739) | 1.53661994 |
| 140 | Steatorrhea (HP:0002570) | 1.51141663 |
| 141 | Hematochezia (HP:0002573) | 1.51020988 |
| 142 | Diminished movement (HP:0002374) | 1.45870048 |
| 143 | Hemiparesis (HP:0001269) | 1.45333239 |
| 144 | Progressive hearing impairment (HP:0001730) | 1.44688857 |
| 145 | Acute hepatic failure (HP:0006554) | 1.43373569 |
| 146 | Microretrognathia (HP:0000308) | 1.41784240 |
| 147 | Neoplasm of the adrenal gland (HP:0100631) | 1.41412406 |
| 148 | Neonatal hypoglycemia (HP:0001998) | 1.39183157 |
| 149 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.36112509 |
| 150 | Abnormality of the labia minora (HP:0012880) | 1.34690000 |
| 151 | Adrenal hypoplasia (HP:0000835) | 1.34292769 |
| 152 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.34032320 |
| 153 | Palpitations (HP:0001962) | 1.33182015 |
| 154 | Thyroid carcinoma (HP:0002890) | 1.31707935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.93631869 |
| 2 | WNK3 | 5.03991366 |
| 3 | WNK4 | 4.74446075 |
| 4 | MAPK15 | 4.47580834 |
| 5 | PASK | 3.98627390 |
| 6 | TAOK3 | 3.77230017 |
| 7 | FGFR2 | 3.66151277 |
| 8 | FRK | 2.80077227 |
| 9 | HIPK2 | 2.61571617 |
| 10 | MAP3K2 | 2.54115304 |
| 11 | PRKD3 | 2.51173810 |
| 12 | DAPK2 | 2.31570196 |
| 13 | PIK3CG | 2.29103191 |
| 14 | OXSR1 | 2.04090352 |
| 15 | UHMK1 | 2.02017702 |
| 16 | PINK1 | 1.99553496 |
| 17 | STK39 | 1.68093136 |
| 18 | TRPM7 | 1.64408271 |
| 19 | STK38L | 1.56614488 |
| 20 | WNK1 | 1.53861257 |
| 21 | STK3 | 1.53608881 |
| 22 | MAP3K1 | 1.51851183 |
| 23 | NTRK1 | 1.50745756 |
| 24 | ERN1 | 1.48699480 |
| 25 | PDK2 | 1.37092699 |
| 26 | IRAK1 | 1.35612194 |
| 27 | FLT3 | 1.32555702 |
| 28 | SCYL2 | 1.32051223 |
| 29 | PTK2 | 1.31688973 |
| 30 | EPHA3 | 1.29477162 |
| 31 | MAP2K6 | 1.26719604 |
| 32 | MST4 | 1.26332497 |
| 33 | IRAK3 | 1.25389936 |
| 34 | PAK3 | 1.20583382 |
| 35 | ACVR1B | 1.17190456 |
| 36 | DYRK1B | 1.13577559 |
| 37 | PDGFRA | 1.11869551 |
| 38 | MET | 1.11120454 |
| 39 | PRKCH | 1.10039391 |
| 40 | CAMKK2 | 1.08854174 |
| 41 | CDC42BPA | 1.05524811 |
| 42 | PRKD2 | 1.00756799 |
| 43 | MAP3K9 | 1.00185531 |
| 44 | NTRK3 | 0.98427867 |
| 45 | AKT3 | 0.96398353 |
| 46 | EPHB1 | 0.95726771 |
| 47 | PTK6 | 0.94555059 |
| 48 | MAP3K7 | 0.91574385 |
| 49 | CASK | 0.87361522 |
| 50 | MAP3K12 | 0.85697732 |
| 51 | STK24 | 0.83931589 |
| 52 | LATS1 | 0.81950123 |
| 53 | SGK494 | 0.81873597 |
| 54 | SGK223 | 0.81873597 |
| 55 | STK16 | 0.80892289 |
| 56 | LMTK2 | 0.79983117 |
| 57 | BMPR1B | 0.79899249 |
| 58 | STK11 | 0.78221002 |
| 59 | ADRBK2 | 0.75734996 |
| 60 | IRAK2 | 0.74783700 |
| 61 | PRKAA1 | 0.72462250 |
| 62 | TAOK1 | 0.71601809 |
| 63 | CSNK1G1 | 0.70918751 |
| 64 | EIF2AK3 | 0.66349489 |
| 65 | GRK1 | 0.66154052 |
| 66 | STK38 | 0.65603282 |
| 67 | MAP3K3 | 0.63445888 |
| 68 | PKN2 | 0.61083731 |
| 69 | BRSK2 | 0.61016154 |
| 70 | FER | 0.58477293 |
| 71 | GSK3A | 0.58472191 |
| 72 | MARK2 | 0.57733207 |
| 73 | EPHA2 | 0.56866794 |
| 74 | MAP3K4 | 0.56721215 |
| 75 | TRIB3 | 0.56495992 |
| 76 | JAK2 | 0.56361044 |
| 77 | SIK1 | 0.55915583 |
| 78 | ITK | 0.54500900 |
| 79 | SGK2 | 0.54458613 |
| 80 | CDK3 | 0.53995414 |
| 81 | FGFR4 | 0.53615885 |
| 82 | TNIK | 0.53294152 |
| 83 | PTK2B | 0.51075833 |
| 84 | BCR | 0.50336919 |
| 85 | MAP2K2 | 0.49110120 |
| 86 | CAMK2D | 0.48962800 |
| 87 | PRKCE | 0.48754965 |
| 88 | RET | 0.46443795 |
| 89 | STK4 | 0.46181578 |
| 90 | TESK1 | 0.45882332 |
| 91 | YES1 | 0.44744685 |
| 92 | SGK3 | 0.44354103 |
| 93 | PLK2 | 0.43715120 |
| 94 | TRIM28 | 0.43326762 |
| 95 | MTOR | 0.42834417 |
| 96 | MAP4K2 | 0.40873284 |
| 97 | NLK | 0.39773848 |
| 98 | NEK6 | 0.37372927 |
| 99 | KSR2 | 0.37325989 |
| 100 | PRKACG | 0.36238629 |
| 101 | DYRK1A | 0.36233426 |
| 102 | JAK1 | 0.35714781 |
| 103 | SGK1 | 0.35324103 |
| 104 | BRD4 | 0.34804872 |
| 105 | PDGFRB | 0.34803052 |
| 106 | BCKDK | 0.34059736 |
| 107 | PRKD1 | 0.33832588 |
| 108 | PRKACA | 0.33372946 |
| 109 | EIF2AK1 | 0.31799726 |
| 110 | CSNK1A1 | 0.31618931 |
| 111 | LIMK1 | 0.31292713 |
| 112 | PRKCI | 0.31238672 |
| 113 | NME1 | 0.31230686 |
| 114 | PRKCZ | 0.31141563 |
| 115 | CSNK1G2 | 0.30515930 |
| 116 | DAPK1 | 0.29478668 |
| 117 | CSNK1G3 | 0.29462287 |
| 118 | CAMK1G | 0.29272695 |
| 119 | PDK1 | 0.29225569 |
| 120 | OBSCN | 0.29123971 |
| 121 | CAMK1D | 0.28654321 |
| 122 | PRKAA2 | 0.28553125 |
| 123 | ADRBK1 | 0.28278456 |
| 124 | PRKG2 | 0.26945699 |
| 125 | CAMK2B | 0.26526583 |
| 126 | PRKG1 | 0.26515317 |
| 127 | IRAK4 | 0.26487453 |
| 128 | PAK6 | 0.26063621 |
| 129 | ALK | 0.25952832 |
| 130 | PLK3 | 0.25424719 |
| 131 | CSNK1E | 0.24695021 |
| 132 | IGF1R | 0.22849399 |
| 133 | ICK | 0.22764221 |
| 134 | PHKG2 | 0.22411919 |
| 135 | PHKG1 | 0.22411919 |
| 136 | CDK5 | 0.21666110 |
| 137 | ERBB3 | 0.21157277 |
| 138 | BMPR2 | 0.20723943 |
| 139 | FGFR3 | 0.20459520 |
| 140 | BRAF | 0.20161977 |
| 141 | PRKDC | 0.19944368 |
| 142 | RPS6KA2 | 0.18283328 |
| 143 | CHUK | 0.17448344 |
| 144 | NUAK1 | 0.17180528 |
| 145 | PNCK | 0.16871989 |
| 146 | RPS6KA3 | 0.16803837 |
| 147 | CDK12 | 0.15732878 |
| 148 | MAPK14 | 0.15236925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.02270092 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.17426471 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.37487019 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.17685326 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.83950788 |
| 6 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.58974227 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.22776217 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.96090778 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.86060791 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85784845 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76176774 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60837265 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.52630930 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51095577 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39175752 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30542422 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30335949 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27473875 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.24919748 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24666277 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23327217 |
| 22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.22752712 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18363309 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17665967 |
| 25 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.13729397 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.12458151 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.08117486 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06846042 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05776427 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02607806 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02123142 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 0.96033421 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89084248 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 0.88693592 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86154117 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.85873544 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84641260 |
| 38 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82089651 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81017258 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80215930 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76644932 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75925426 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71714687 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71337832 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.70253134 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69549022 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69102483 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68904835 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68187266 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67987163 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67771248 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66967106 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66484875 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64444625 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 0.61896957 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61274107 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60042749 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58641216 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57239442 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56857577 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56826807 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56145656 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55434585 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54714451 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54450514 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53975563 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53862130 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52462864 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52427224 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.49842933 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48774879 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48571733 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48241733 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48177956 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47586044 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46043720 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45968698 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44022972 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43662192 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.42806656 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41494908 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40871696 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40169870 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39564081 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.39218942 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.39211369 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39124452 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38136327 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37679834 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37651745 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37629684 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36061169 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36023456 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35708417 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35557615 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35011885 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.34733619 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33682459 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33112911 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.32934102 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31791073 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31740107 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.31727470 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.30112844 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29090430 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27622322 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27470443 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27365435 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.26486066 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26448055 |
| 111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26430766 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.25852856 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24413802 |
| 114 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.22134333 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21837892 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.21411308 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.20872331 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20597501 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19965770 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19764432 |

